Research Article
Serum Metabonomics Analysis of Liver Failure Treated by Nonbioartificial Liver Support Systems
Table 11
Identification of characteristic metabolites about chronic liver failure with nonbioartificial liver.
| Comparison of treatment methods | Detection of mass/charge ratio | The theory of mass/charge ratio | metabolite | VIP value |
| Plasma exchange and Bilirubin adsorption | 167.0 | 168.1 | uric acid | 2.03 | 407.3 | 408.6 | Cholic acid | 1.61 | 112.1 | 113.1 | creatinine | 1.58 | 391.3 | 392.6 | anthropodesoxycholic acid | 1.16 | 303.2 | 304.5 | FFA 20_4 | 1.09 | 167.0 | 515.7 | cholaic acid | 1.11 | 286.3 | 284.5 | FFA 18_0-d3 | 1.08 |
| Plasma exchange and Hemofiltration | 167.0 | 168.1 | uric acid | 2.03 | 407.3 | 408.6 | cholalic acid | 1.61 | 112.1 | 113.1 | creatinine | 1.58 | 391.3 | 392.6 | anthropodesoxycholic acid | 1.16 | 303.2 | 304.5 | FFA 20_4 | 1.09 | 281.3 | 282.5 | FFA 18_1 | 1.40 | 178.1 | 178.2 | hippuric acid | 1.33 | 203.1 | 204.2 | L- tryptophan | 1.16 |
| Hemofiltration and Bilirubin adsorption | 281.3 | 282.5 | FFA 18_1 | 1.40 | 498.3 | 281.2 | phenylacetylglutamine | 1.28 |
|
|
Note. VIP: variable importance in projection.
|